- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Pall Life Sciences
Tel: 41 26 350 53 00
Fax: +41 (0)26 350 53 53
Other contact details
For regional offices, distributors and agents by country, please visit www.pall.com/contact.asp
Pall Life Sciences provides systems for rapid microbiology and qPCR, as well as a complete range of sampling devices, membranes, filters and sample concentrators for all aspects of microbiology and environmental monitoring.
Pall Life Sciences also manufactures approved systems for rapid bacterial detection in the clinical and blood donor setting. These are part of the compete portfolio of Pall Life Sciences technologies that encompass the Pall credo of 'Total Fluid Management'.
Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing total Fluid ManagementSM solutions to meet the critical needs of customers in biopharmaceutical, hospital and transfusion medicine, energy and alternative energy, electronics, municipal and industrial water, aerospace, transportation and broad industrial markets. Together with our customers, we foster health, safety and environmentally responsible technologies. The Company's engineered solutions enable process and product innovation and minimize emissions and waste.
Pall Corporation, with total revenues of $2.3 billion for fiscal 2009, is an S&P 500 company with more than 10,000 employees servicing customers worldwide. Pall has been named a top 'green company' by Newsweek magazine. To see how Pall is helping enable a greener and more sustainable future, visit www.pall.com.